Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial

BACKGROUND: The peritoneum is the second most common site of recurrence in colorectal cancer. Early detection of peritoneal carcinomatosis (PC) by imaging is difficult. Patients eventually presenting with clinically apparent PC have a poor prognosis. Median survival is only about five months if untr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Klaver, Charlotte E L, Musters, Gijsbert D, Bemelman, Willem A, Punt, Cornelis J A, Verwaal, Victor J, Dijkgraaf, Marcel GW, Aalbers, Arend GJ, van der Bilt, Jarmila DW, Boerma, Djamila, Bremers, Andre JA, Burger, Jacobus WA, Buskens, Christianne J, Evers, Pauline, van Ginkel, Robert J, van Grevenstein, Wilhelmina MU, Hemmer, Patrick HJ, de Hingh, Ignace HJT, Lammers, Laureen A, van Leeuwen, Barbara L, Meijerink, Wilhelmus JHJ, Nienhuijs, Simon W, Pon, Jolien, Radema, Sandra A, van Ramshorst, Bert, Snaebjornsson, Petur, Tuynman, Jurriaan B, te Velde, Elisabeth A, Wiezer, Marinus J, de Wilt, Johannes HW, Tanis, Pieter J
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2015
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4492087/
https://ncbi.nlm.nih.gov/pubmed/26003804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1430-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky